Sectors
SXTC
China SXT Pharmaceuticals, Inc.
1.89
2 x 1.39
2 x 2.35
bid
ask
+
0.09
5.00%
2 @ 04:00 PM
1.83 -0.06 (3.17%)
Ytd -99.21%
1y -99.51%
1.82
day range
1.94
1.30
52 week range
429.00
Open 1.83 Prev Close 1.80 Low 1.82 High 1.94 Mkt Cap 1.61M
Vol 66.80K Avg Vol 308.28K EPS -57.15 P/E N/A Forward P/E N/A
Beta 1.16 Short Ratio 0.52 Inst. Own 1.35% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning N/A 50-d Avg 3.48 200-d Avg 168.32 1yr Est 0.00
Upgrade / Downgrade
Date Firm Action From To
Profile
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
Institution Ownership
Report Date Organization Position Value Percentage
2024-09-29 Baader Bank Aktiengesellschaft 15.16K 5.26K 0.37%
2024-09-29 Gsa Capital Partners Llp 12.30K 4.26K 0.30%
2024-09-29 Bank of Montreal /CAN/ 10.00K 3.47K 0.25%
2024-09-29 UBS Group AG 8.68K 3.01K 0.21%
2024-09-29 JP Morgan Chase & Company 376.00 130.00 0.01%
2024-09-29 Acadian Asset Management. LLC 379.00 131.00 0.01%
Fund Ownership
Report Date Organization Position Value Percentage
2023-10-30 Fidelity NASDAQ Composite Index Fund 54.00 18.00 0.00%
Split
Split Date
1 : 150 2026-02-03
1 : 8 2025-02-25
1 : 25 2023-10-05
1 : 20 2022-05-19
1 : 4 2021-02-22